BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 23789951)

  • 1. Human ABC transporters at blood-CNS interfaces as determinants of CNS drug penetration.
    Chaves C; Shawahna R; Jacob A; Scherrmann JM; Declèves X
    Curr Pharm Des; 2014; 20(10):1450-62. PubMed ID: 23789951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle- and liposome-carried drugs: new strategies for active targeting and drug delivery across blood-brain barrier.
    Pinzón-Daza ML; Campia I; Kopecka J; Garzón R; Ghigo D; Riganti C
    Curr Drug Metab; 2013 Jul; 14(6):625-40. PubMed ID: 23869808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioids and the Blood-Brain Barrier: A Dynamic Interaction with Consequences on Drug Disposition in Brain.
    Chaves C; Remiao F; Cisternino S; Decleves X
    Curr Neuropharmacol; 2017 Nov; 15(8):1156-1173. PubMed ID: 28474563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-brain barrier active efflux transporters: ATP-binding cassette gene family.
    Löscher W; Potschka H
    NeuroRx; 2005 Jan; 2(1):86-98. PubMed ID: 15717060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid transport by ATP-binding cassette transporters at the blood-brain barrier: implications for neuropsychopharmacology.
    Tournier N; Declèves X; Saubaméa B; Scherrmann JM; Cisternino S
    Curr Pharm Des; 2011; 17(26):2829-42. PubMed ID: 21827411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay of drug metabolizing CYP450 enzymes and ABC transporters in the blood-brain barrier.
    Decleves X; Jacob A; Yousif S; Shawahna R; Potin S; Scherrmann JM
    Curr Drug Metab; 2011 Oct; 12(8):732-41. PubMed ID: 21623707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?
    Sanchez-Covarrubias L; Slosky LM; Thompson BJ; Davis TP; Ronaldson PT
    Curr Pharm Des; 2014; 20(10):1422-49. PubMed ID: 23789948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABC transporters and drug efflux at the blood-brain barrier.
    Shen S; Zhang W
    Rev Neurosci; 2010; 21(1):29-53. PubMed ID: 20458886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restricting CNS penetration of drugs to minimise adverse events: role of drug transporters.
    Bagal S; Bungay P
    Drug Discov Today Technol; 2014 Jun; 12():e79-85. PubMed ID: 25027378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABC transporters and the blood-brain barrier.
    Begley DJ
    Curr Pharm Des; 2004; 10(12):1295-312. PubMed ID: 15134482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioligands targeting P-glycoprotein and other drug efflux proteins at the blood-brain barrier.
    Wanek T; Mairinger S; Langer O
    J Labelled Comp Radiopharm; 2013; 56(3-4):68-77. PubMed ID: 24285312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of ATP-binding cassette transporters at the inner blood-retinal barrier in a neonatal mouse model of oxygen-induced retinopathy.
    Tagami M; Kusuhara S; Honda S; Tsukahara Y; Negi A
    Brain Res; 2009 Aug; 1283():186-93. PubMed ID: 19505448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunction of ABC transporters at the blood-brain barrier: Role in neurological disorders.
    Gil-Martins E; Barbosa DJ; Silva V; Remião F; Silva R
    Pharmacol Ther; 2020 Sep; 213():107554. PubMed ID: 32320731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting CNS transporters for treatment of neurodegenerative diseases.
    Jedlitschky G; Grube M; Mosyagin I; Kroemer HK; Vogelgesang S
    Curr Pharm Des; 2014; 20(10):1523-33. PubMed ID: 23789959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting transporters for CNS drug delivery.
    Ronaldson PT
    Curr Pharm Des; 2014; 20(10):1419-21. PubMed ID: 23789947
    [No Abstract]   [Full Text] [Related]  

  • 16. PET Studies on P-glycoprotein function in the blood-brain barrier: how it affects uptake and binding of drugs within the CNS.
    Elsinga PH; Hendrikse NH; Bart J; Vaalburg W; van Waarde A
    Curr Pharm Des; 2004; 10(13):1493-503. PubMed ID: 15134571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Expression of P-glycoprotein and Organic Anion Transporting Polypeptides at the Blood-Brain Barrier: Understanding Transport Mechanisms for Improved CNS Drug Delivery?
    Abdullahi W; Davis TP; Ronaldson PT
    AAPS J; 2017 Jul; 19(4):931-939. PubMed ID: 28447295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABC transporter regulation by signaling at the blood-brain barrier: relevance to pharmacology.
    Miller DS
    Adv Pharmacol; 2014; 71():1-24. PubMed ID: 25307212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ABC of the blood-brain barrier - regulation of drug efflux pumps.
    Mahringer A; Ott M; Reimold I; Reichel V; Fricker G
    Curr Pharm Des; 2011; 17(26):2762-70. PubMed ID: 21827407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of ABC membrane transporters in glial cells: relevance to the pharmacotherapy of brain HIV-1 infection.
    Ronaldson PT; Persidsky Y; Bendayan R
    Glia; 2008 Dec; 56(16):1711-35. PubMed ID: 18649402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.